GET THE APP

Atherogenic Dyslipidemia Top Journals | Open Access Journals
Journal of Metabolic Syndrome

Journal of Metabolic Syndrome

ISSN: 2167-0943

Open Access

Atherogenic Dyslipidemia Top Journals

Atherogenic dyslipidemia (AD) alludes to raised degrees of triglycerides (TG) and little thick low-thickness lipoprotein and low degrees of high-thickness lipoprotein cholesterol (HDL-C). Also, raised degrees of enormous TG rich extremely low-thickness lipoproteins, apolipoprotein B and oxidized low-thickness lipoprotein (LDL), and diminished degrees of little high-thickness lipoproteins assumes a basic job in AD. Every one of the three components of AD in essence have been perceived as free hazard factor for cardiovascular illness. Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In developed countries, most dyslipidemias are hyperlipidemias; that is, an elevation of lipids in the blood. This is often due to diet and lifestyle.

High Impact List of Articles
Conference Proceedings

Relevant Topics in Genetics & Molecular Biology

Google Scholar citation report
Citations: 48

Journal of Metabolic Syndrome received 48 citations as per Google Scholar report

Journal of Metabolic Syndrome peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward